Navigation Links
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Date:5/13/2008

said Paul LaViolette, Chief Operating Officer of Boston Scientific. "With the anticipated FDA approval of the XIENCE V (PROMUS) Stent and the launch of the TAXUS Liberte Stent this year, we are excited to offer physicians and their patients two drugs on two highly deliverable platforms."

The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific. The PROMUS and TAXUS Liberte(R) Stents have received CE Mark approval and are distributed in most European countries and other international markets. The XIENCE V (PROMUS) Stent is an investigational device in the U.S. and not yet approved for sale. It is currently under FDA review with an anticipated U.S. launch in 2008.

SPIRIT III is sponsored by Abbott. TAXUS, TAXUS Express2, Express, Liberte and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of Abbott Laboratories Group of Companies.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, product performance and competitive offering
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
2. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
3. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
4. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
5. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. DATATRAK International Reports First Quarter Results for 2008
8. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
9. Exelixis Announces First Quarter 2008 Financial Results
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... --  Quest Diagnostics (NYSE: DGX ), ... celebrates a decade on the North America Dow Jones ... World DJSI. The Dow Jones Sustainability ... economic, environmental and social criteria. To be included or ... sustainability initiatives. "A sustainable business is a ...
(Date:9/12/2014)... 12, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... focused on chronic inflammatory disease and neurologic disorders, ... from the U.S. Food and Drug Administration (FDA) ... (NDIN) for the formulations of Anatabloc® and CigRx® submitted ... indicated that the FDA considers anatabine citrate, a principal ...
(Date:9/11/2014)... Fla. , Sept. 11, 2014 ... cancer-treatment research and development firm, has discovered substances ... sediment samples that were recovered from the ocean ... and Recovery Limited Partnership. Logo - ... exciting as the discovery of Gold Rush-era treasure ...
Breaking Medicine Technology:Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 3Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep 2Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep 3
(Date:9/15/2014)... September 15, 2014 Stem cells are ... and can divide (through mitosis) to produce more stem ... of cardiovascular diseases, leukemia (a kind of hematological system ... kidney and other parenchymal organs, etc. , Currently, cord ... amid stem cell upstream sectors and even the whole ...
(Date:9/15/2014)... In addition to hosting, Stone Chiropractic ... Chair massages will be offered by Katherine Smith LLMT, ... homemade jams and muffins. Elaine Bauman from Beauty ... teach about doTERRA Essential Oils while Amira Watters will ... from face-painting to a coloring table and more. ...
(Date:9/15/2014)... 15, 2014 Ticketability.com can offer online customers ... Toyota Center, and Smoothie King Center. Fans are happy to ... first headlining tour in a period of three years. , ... 2014 concerts at Ticketability.com. , Colorado concertgoers who reside in ... 1st Bank Center. Texas fans have two chances to see ...
(Date:9/15/2014)... 2014 Recently, Top 10 Best ... compared many web hosting companies and announced that ... best suppliers for webmasters from all over the ... hosting plan. The company’s approach to hosting is ... accessible and powerful enough for anyone to use. ...
(Date:9/15/2014)... With a simple swab of the cheek, ... insight to help personalize the treatment for patients with vascular ... ideal approach to medicine is preventive care. But, it can ... will respond to specific drugs. A simple cheek swab test ... the physician to tailor medical therapy and optimize outcomes. , ...
Breaking Medicine News(10 mins):Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 2Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 3Health News:Ticketability.com Unleashes 2014 Usher Tickets for 1st Bank Center, American Airlines Center, Toyota Center, and Smoothie King Center Concerts 2Health News:Top 10 Best SEO Hosting: Justhost And Bluehost Are The Best Suppliers For Webmasters 2Health News:Center for Vascular Medicine Offers Genetic Testing For Personalized Vascular Care 2
... that combination asthma therapy, SYMBICORT leads to significant ... greater patient-reported satisfaction with asthma treatment, versus ... ,SYMBICORT is a recently approved, combination therapy ... in patients 12 years of age and older. ...
... imaging technique - magnetic resonance elastography (MRE) - is an ... ,The studies were conducted by a team of ... ,As part of one study, researchers conducted MRE examinations of ... ,The researchers found that MRE accurately detects ...
... bumps and bruises to contribute to a hostile ... harms another individual, through the manipulation of ... significant a concern for adolescent psychosocial development and ... Montclair State University and her colleagues from the ...
... joined forces with Canadian biotech company GangaGen Life Sciences ... food poisoning . ,They are engaging in ... control of Campylobacter the commonest cause of infectious ... the Health Protection Agency. Campylobacters are found in poultry ...
... Alzheimers one more breakthrough has been achieved. Scientists in New ... of mice using a magnetic stimulus in the region ... at the American Academy for Neuroscience conference. If proven, the ... Alzheimers disease, if not a cure. ,Experts ...
... A new study has found that obese patients with asthma ... those who are not overweight . ,The study ... Fernando Holguin and colleagues at Emory University. ,As ... than 3,000 adults by examining a data from the four-state ...
Cached Medicine News:Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:Psychological Bullying Hits Just as Hard 2Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:Magnets to the rescue of Alzheimers patients 2Health News:Obesity Might Lead to Severe Persistent Asthma Attacks: Study 2
... Detect™ IgM Capture ELISA is for the ... WNV recombinant antigens (WNRA) in serum as ... of West Nile virus infection in patients ... results must be confirmed by Plaque Reduction ...
Adult; dilates 6.0 to 34.0 French; individually packaged, sterile....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: